NIH Is Advised To Expand Its International Activities

Sidebar: Advisory Panel's Recommendations to NIH But budget concerns may force the agency's heralded Fogarty Center to stand pat A comparatively small proposed budget increase for the center that coordinates international programs of the National Institutes of Health may prevent any significant expansion of its global efforts in the near future. A report submitted last fall by an external advisory panel recommended "a strengthening of international activities" at NIH (see list of recommendatio

Written byThomas Durso
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Sidebar: Advisory Panel's Recommendations to NIH

A report submitted last fall by an external advisory panel recommended "a strengthening of international activities" at NIH (see list of recommendations on page 3). The report also advised that the John C. Fogarty International Center (FIC) remain the focal point for NIH's international programs and "embark on additional activities" in collaboration with NIH's institutes, centers, and divisions (ICDs) "to advance science and promote global health." But the fiscal year 1998 budget submitted by President Clinton in early February would raise FIC's funding by only $600,000-from this year's estimated $26.6 million to next year's proposed $27.2 million.


THINK GLOBALLY: The Fogarty International Center is housed on NIH’s Bethesda, Md., campus.

FIC director Philip E. Schambra is optimistic that, regardless of grim budget figures, NIH's international commitment can and should expand. "There's a feeling across the government that we have tightened our belts, as related ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies